Organogenesis Holdings Inc (ORGO) Stock Price, Quote & News

Company Profile

Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity and Novachor, which are amnion and chorion placental allografts for use in the care of chronic and acute wounds as protective barriers and extracellular matrix (ECM) scaffolds; Apligraf, a bioengineered bi-layered skin substitute for...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 781 575 0775

Website: organogenesis.com

Address:

85 Dan Road, Canton, United States

SuperGreenToday Dec. 5 at 9:46 PM

$ORGO Share Price: $4.74 Contract Selected: Jul 17, 2026 $5 Calls Buy Zone: $0.85 – $1.05 Target Zone: $1.53 – $1.87 Potential Upside: 70% ROI Time to Expiration: 223 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Mobagri Dec. 5 at 8:51 PM

$ORGO shorts will regret again. They don’t learn their lesson. Coming soon. In the meantime great great buying opportunity

0 · Reply

LDT79 Dec. 5 at 4:20 PM

$ORGO 20% short interest - this is not going anywhere

0 · Reply

meowmeow5 Dec. 5 at 2:47 PM

$ORGO is this some sort of sick joke

0 · Reply

jdlman Dec. 5 at 6:49 AM

$ORGO buying the dip

0 · Reply

Mobagri Dec. 4 at 10:02 PM

$ORGO like always this thing shoots up and people are we missed the chance. This is the chance before December 12th.

1 · Reply

LDT79 Dec. 4 at 4:07 PM

$ORGO how the fuck is this shit trading???

0 · Reply

Amorrr Dec. 1 at 11:43 PM

$ORGO I think 4.95~4.94 is the bottom short term.

0 · Reply

Amorrr Dec. 1 at 11:19 PM

$ORGO this has to touch 4.80 before recovering and possibly sky-rocketing

0 · Reply

LDT79 Dec. 1 at 4:18 PM

$ORGO motherfucking short sellers!!

0 · Reply

Organogenesis Holdings Inc. (ORGO) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 4:05 PM EST - 4 weeks ago

Organogenesis Holdings Inc. Reports Third Quarter 2025 Financial Results, Posts Record Revenue and Raises 2025 Guidance

Nov 3, 2025, 1:10 PM EST - 4 weeks ago

Organogenesis Applauds CMS's Significant Step In Payment Reform

Oct 31, 2025, 4:05 PM EDT - 5 weeks ago

Organogenesis Holdings Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Oct 17, 2025, 2:20 PM EDT - 7 weeks ago

Organogenesis Holdings Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – ORGO

Oct 1, 2025, 4:05 PM EDT - 2 months ago

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025

Sep 29, 2025, 8:26 AM EDT - 2 months ago

Organogenesis: Mixed ReNu Data, But Policy Tailwinds And Growth Remain Bullish

Sep 26, 2025, 11:24 AM EDT - 2 months ago

Why Is Organogenesis Stock Trading Lower Friday?

Sep 25, 2025, 4:50 PM EDT - 2 months ago

Organogenesis Provides Update on Second Phase 3 ReNu® Study

Aug 27, 2025, 4:05 PM EDT - 3 months ago

Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September

Aug 8, 2025, 6:30 PM EDT - 4 months ago

Organogenesis Holdings Inc. (ORGO) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 5:53 PM EDT - 4 months ago

ORGO Sales Drop 23%

Aug 7, 2025, 4:05 PM EDT - 4 months ago

Organogenesis Holdings Inc. Reports Second Quarter 2025 Financial Results

Jul 22, 2025, 4:05 PM EDT - 4 months ago

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025

Jul 15, 2025, 9:00 AM EDT - 5 months ago

Organogenesis Applauds CMS Proposal to Reform Skin Substitute Payment Policy; Urges Refinements to Ensure Patient Access to Appropriate Products and Continued Innovation

Jun 9, 2025, 5:39 PM EDT - 6 months ago

Organogenesis Holdings: ReNu And New LCD Offer A Rebound Scenario

May 11, 2025, 10:14 AM EDT - 7 months ago

Organogenesis Holdings Inc. (ORGO) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:05 PM EDT - 7 months ago

Organogenesis Holdings Inc. Reports First Quarter 2025 Financial Results

Apr 11, 2025, 4:05 PM EDT - 8 months ago

Organogenesis Supports CMS' Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness

Apr 7, 2025, 4:05 PM EDT - 8 months ago

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

Feb 27, 2025, 8:27 PM EST - 10 months ago

Organogenesis Holdings Inc. (ORGO) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 4:05 PM EST - 10 months ago

Organogenesis Holdings Inc. Reports Fourth Quarter 2024 Financial Results

Jan 27, 2025, 7:30 AM EST - 11 months ago

Organogenesis Holdings Inc. to Report Fourth Quarter of Fiscal Year 2024 Financial Results on February 27, 2025

Nov 22, 2024, 4:05 PM EST - 1 year ago

Organogenesis Expands Manufacturing Capacity to Support Future Growth

Nov 15, 2024, 9:25 AM EST - 1 year ago

Organogenesis Commends Final LCDs

Nov 12, 2024, 11:02 PM EST - 1 year ago

Organogenesis Holdings, Inc. (ORGO) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 4:01 PM EST - 1 year ago

Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock

Nov 11, 2024, 5:05 PM EST - 1 year ago

Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis

Oct 16, 2024, 7:30 AM EDT - 1 year ago

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024

Oct 1, 2024, 4:05 PM EDT - 1 year ago

Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers

Aug 8, 2024, 11:08 PM EDT - 1 year ago

Organogenesis Holdings, Inc. (ORGO) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:04 PM EDT - 1 year ago

Organogenesis Shares ReNu® Program Update

Jul 15, 2024, 4:05 PM EDT - 1 year ago

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024

Jun 6, 2024, 4:05 PM EDT - 1 year ago

Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech Conference

May 9, 2024, 9:01 PM EDT - 1 year ago

Organogenesis Holdings, Inc. (ORGO) Q1 2024 Earnings Call Transcript

May 2, 2024, 7:00 AM EDT - 1 year ago

Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis

Apr 16, 2024, 7:30 AM EDT - 1 year ago

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024

Mar 1, 2024, 6:29 PM EST - 1 year ago

Why Organogenesis Holding Stock Plummeted by 18% Today

Feb 29, 2024, 11:06 PM EST - 1 year ago

Organogenesis Holdings, Inc. (ORGO) Q4 2023 Earnings Call Transcript

Feb 29, 2024, 4:05 PM EST - 1 year ago

Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance

Feb 12, 2024, 7:30 AM EST - 1 year ago

Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference

Feb 8, 2024, 4:05 PM EST - 1 year ago

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024

Nov 9, 2023, 10:16 PM EST - 2 years ago

Organogenesis Holdings, Inc. (ORGO) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 4:05 PM EST - 2 years ago

Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial Results

Oct 5, 2023, 7:30 AM EDT - 2 years ago

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023

Sep 28, 2023, 11:44 AM EDT - 2 years ago

Why Shares of Organogenesis Holdings Are Up Thursday

Sep 28, 2023, 9:15 AM EDT - 2 years ago

Organogenesis Applauds Withdrawal of Local Coverage Determinations by Novitas, First Coast Service Options and CGS

SuperGreenToday Dec. 5 at 9:46 PM

0 · Reply

Mobagri Dec. 5 at 8:51 PM

$ORGO shorts will regret again. They don’t learn their lesson. Coming soon. In the meantime great great buying opportunity

0 · Reply

LDT79 Dec. 5 at 4:20 PM

$ORGO 20% short interest - this is not going anywhere

0 · Reply

meowmeow5 Dec. 5 at 2:47 PM

$ORGO is this some sort of sick joke

0 · Reply

jdlman Dec. 5 at 6:49 AM

$ORGO buying the dip

0 · Reply

Mobagri Dec. 4 at 10:02 PM

$ORGO like always this thing shoots up and people are we missed the chance. This is the chance before December 12th.

1 · Reply

LDT79 Dec. 4 at 4:07 PM

$ORGO how the fuck is this shit trading???

0 · Reply

Amorrr Dec. 1 at 11:43 PM

$ORGO I think 4.95~4.94 is the bottom short term.

0 · Reply

Amorrr Dec. 1 at 11:19 PM

$ORGO this has to touch 4.80 before recovering and possibly sky-rocketing

0 · Reply

LDT79 Dec. 1 at 4:18 PM

$ORGO motherfucking short sellers!!

0 · Reply

LDT79 Nov. 28 at 5:30 PM

$ORGO what's with the shorting?

0 · Reply

Kojiko Nov. 27 at 2:17 PM

$ORGO record revenue guidance and strong tailwind from policy change. Double digits in coming soon.

0 · Reply

meowmeow5 Nov. 26 at 5:35 PM

$ORGO something has to be brewing. Not moving with the market usually is indicative of a problem… or accumulation. I’m going with the latter

0 · Reply

Parnell8 Nov. 26 at 3:44 PM

$ORGO buyouts in space happening with solventum!

1 · Reply

NNNTrader Nov. 24 at 12:40 PM

$ORGO New setup I’m trading this week. My Free Substack has the setup and trade plan.

1 · Reply

NNNTrader Nov. 24 at 3:25 AM

$ORGO New swing trade setup. Why and how I’m trading it⬇️ https://nnntrader.substack.com/p/weekly-pick-orgo

0 · Reply

NNNTrader Nov. 23 at 3:40 PM

$ORGO New sing trade setup. Why and how I’m trading it⬇️ https://nnntrader.substack.com/p/weekly-pick-orgo

0 · Reply

Cmte6 Nov. 21 at 10:23 PM

$ORGO interesting

0 · Reply

meowmeow5 Nov. 21 at 4:25 PM

$ORGO once the market stops panicking we will start seeing regular 20% days

1 · Reply

Kojiko Nov. 21 at 1:46 PM

$ORGO interesting.

0 · Reply

merlin8121 Nov. 20 at 8:33 PM

$ORGO https://www.merlintrader.com/top-10-healthcare-small-caps-stocks/

0 · Reply

meowmeow5 Nov. 20 at 3:57 PM

$ORGO it’s coming!

0 · Reply

Market Cap	601.56M
Revenue (ttm)	482.04M
Net Income (ttm)	860,000.00
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	61.50
Profit Margin	0.18%
Debt to Equity Ratio	0.00

Volume	729,600
Avg Vol	1,758,288
Day's Range	N/A - N/A
Shares Out	126.91M
Stochastic %K	3%
Beta	1.47
Analysts	Strong Sell
Price Target	$8.50